Browse diseases

…bations before or after LT-NIV initiation.Conclusion Coexisting Bronchiectasis increases the risk of infective exacerbations in patients with …

… airflow limitation (OR 2.22 (95% CI 1.75 to 2.82)).Conclusions Bronchiectasis is an independent risk factor for airflow limitation, and disea…

…atistically significant p = 0.0114 (<0.05)Conclusion Historical asthma diagnoses are common in bronchiectasis patients, but updated gu…

… 95% CI 1.11 to 2.70) were associated with an increased risk of bronchiectasis. In contrast, obesity was inversely associated with the risk of…

…y support more equitable access to this essential treatment for bronchiectasis patients.…

…Bronchiectasis is a heterogeneous lung disease. There is an increasing focus o…

…OS is relatively good, despite yearly fluctuations, whereas for Bronchiectasis, COS uptake is limited. Further research into standardised meas…

…sician-reported exacerbation frequencyConclusions Patients with bronchiectasis experienced symptoms even if they had no physician-reported exa…

…of the cohort was 64 years and 62% were female. The most common bronchiectasis aetiology was idiopathic or post-infectious. Across follow-ups,…

…Bronchiectasis is a heterogeneous disease characterised by chronic inflammatio…

… BTS guidelines have not detailed the impact of polypharmacy in bronchiectasis patients.Methods Adult patients with a clinical diagnosis of br…

…osts attributable to inpatient-managed exacerbations.Conclusion Bronchiectasis and associated exacerbations are a significant cost to the NHS.…